Literature DB >> 2560392

Seizure-like activity and cellular damage in rat hippocampal neurons in cell culture.

E J Furshpan1, D D Potter.   

Abstract

Neurons dissociated from the hippocampal formations of neonatal rats were grown in medium containing kynurenic acid (a glutamate receptor antagonist) and elevated Mg2+. Such chronically blocked neurons, when first exposed to medium without blockers (after 0.5-5.0 months), generated intense seizure-like activity. This consisted of bursts of synchronous electrical responses that resembled paroxysmal depolarization shifts and sustained depolarizations that, in some neurons, nearly abolished the resting potential. Sustained depolarizations were usually reversed by timely application of kynurenate or 2-amino-5-phosphonovalerate, indicating that continuous activation of glutamate receptors was required for their maintenance. Prolonged periods of intense seizure-like activity usually killed most neurons in the culture. This system allows seizure-related cellular mechanisms to be studied in long-term cell culture.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2560392     DOI: 10.1016/0896-6273(89)90033-0

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  26 in total

1.  cAMP-dependent protein kinase mediates activity-regulated synaptic targeting of NMDA receptors.

Authors:  F T Crump; K S Dillman; A M Craig
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  Controlling bursting in cortical cultures with closed-loop multi-electrode stimulation.

Authors:  Daniel A Wagenaar; Radhika Madhavan; Jerome Pine; Steve M Potter
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

3.  Synapse-specific adaptations to inactivity in hippocampal circuits achieve homeostatic gain control while dampening network reverberation.

Authors:  Jimok Kim; Richard W Tsien
Journal:  Neuron       Date:  2008-06-26       Impact factor: 17.173

4.  Local synaptic release of glutamate from neurons in the rat hypothalamic arcuate nucleus.

Authors:  A B Belousov; A N van den Pol
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

5.  The hippocampus: detailed assessment of normative two-dimensional measurements, signal intensity, and subfield conspicuity on routine 3T T2-weighted sequences.

Authors:  Erik H Middlebrooks; Ronald G Quisling; Michael A King; Paul R Carney; Steven Roper; Luis M Colon-Perez; Thomas H Mareci
Journal:  Surg Radiol Anat       Date:  2017-03-12       Impact factor: 1.246

Review 6.  Models of drug-induced epileptiform synchronization in vitro.

Authors:  Massimo Avoli; John G R Jefferys
Journal:  J Neurosci Methods       Date:  2015-10-17       Impact factor: 2.390

7.  Acetylcholine becomes the major excitatory neurotransmitter in the hypothalamus in vitro in the absence of glutamate excitation.

Authors:  A B Belousov; B F O'Hara; J V Denisova
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

8.  Suppression of TNF receptor-1 signaling in an in vitro model of epileptic tolerance.

Authors:  Simon J Thompson; Michelle D Ashley; Sabine Stöhr; Clara Schindler; Minghua Li; Kristin A McCarthy-Culpepper; Andrea N Pearson; Zhi-Gang Xiong; Roger P Simon; David C Henshall; Robert Meller
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-06-13

9.  Regulation of intrinsic excitability in hippocampal neurons by activity-dependent modulation of the KV2.1 potassium channel.

Authors:  Durga P Mohapatra; Hiroaki Misonou; Sheng-Jun Pan; Joshua E Held; D James Surmeier; James S Trimmer
Journal:  Channels (Austin)       Date:  2009 Jan-Feb       Impact factor: 2.581

10.  Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy.

Authors:  Sachiko Shinoda; Clara K Schindler; Robert Meller; Norman K So; Tomohiro Araki; Akitaka Yamamoto; Jing-Quan Lan; Waro Taki; Roger P Simon; David C Henshall
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.